melodius27, GRPN is a totally different biz model than DMD.
And EPS data doesn't tell you much about the strength of an interent growth stock All things considered, EPS is pretty useless when looking at a new company (founded in 2006) that just went public last year.
Earnings per share are now positive if you've been paying attention. Besides, earnings are only one measurement of many to look at when investing. It's typical for young companies such as DMD to focus on growth/revenue before earnings.